Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

63336-U

Supelco

BIOshell lgG 1000 Å C4 (2.7 μm) HPLC Columns

L × I.D. 5 cm × 300 μm, HPLC Column

Synonym(s):

BIOshell IgG 1000 Å C4, 2.7 μm HPLC Column

Sign Into View Organizational & Contract Pricing

Select a Size

Change View
10 MG
₩207,162

About This Item

UNSPSC Code:
41115709
NACRES:
SB.52

₩207,162

Please contact Customer Service for Availability
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

BIOshell lgG 1000 Å C4, 2.7 μm HPLC Column, column L × I.D. 5 cm × 300 μm

material

stainless steel hardware

Quality Level

100

Agency

suitable for USP L26

description

Shell thickness (0.5 μm)
Solid core (1.7 μm)

product line

BIOshell

feature

endcapped

packaging

pkg of 1 unit

extent of labeling

0.6% carbon loading

parameter

90 °C max. temp.

technique(s)

HPLC: suitable

column L × I.D.

5 cm × 300 μm

surface area

22 m2/g

matrix

spherical silica particle platform

matrix active group

C4 (butyl) phase

particle size

2.7 μm

pore size

1000 Å

operating pH range

2-9

separation technique

reversed phase

General description

BIOshell IgG 1000Å C4 is a high-speed, high-performance liquid chromatography column based on a new wide-pore (1000Å) Fused-Core® particle design. The Fused-Core particle provides a thin porous shell of high-purity silica surrounding a solid silica core. This particle design exhibits very high column efficiency due to the shallow diffusion paths in the 0.5-micron thin porous shell and the small overall particle size of 2.7-microns. The densely bonded, extensively endcapped dimethylbutyl stationary phase of BIOshell IgG 1000Å C4 provides a stable, reversed-phase packing that can be used for separating high molecular weight compounds such as proteins.

Application

UHPLC Analysis of Trastuzumab on BIOshell IgG 1000 Å C4, 2.7 μm
UHPLC Analysis of IgG2 on BIOshell IgG 1000 Å C4, C18, and Diphenyl, 2.7 μm

Legal Information

Fused-Core is a registered trademark of Advanced Materials Technology, Inc.

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
SYNPLE-BT022SYNPLE-BT033SYNPLE-BT023
Sigma-Aldrich

SYNPLE-BT032

Reagent-cartridge Biotin tag-PEG2-COOTfp

Sigma-Aldrich

SYNPLE-BT022

Reagent-cartridge Biotin tag-PEG2-a-COOTfp

Sigma-Aldrich

SYNPLE-BT033

Reagent-cartridge Biotin tag-PEG3-COOTfp

Sigma-Aldrich

SYNPLE-BT023

Reagent-cartridge Biotin tag-PEG3-a-COOTfp

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

parameter

up to 0.1 mmol scale

parameter

up to 0.1 mmol scale

parameter

up to 0.1 mmol scale

parameter

up to 0.1 mmol scale

Still not finding the right product?

Explore all of our products under BIOshell lgG 1000 Å C4, 2.7 μm HPLC Column

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    USRTX001304
    USRTX001303
    USRTX001301

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Benoit Pilmis et al.
    Medecine sciences : M/S, 29 Spec No 1, 25-30 (2013-05-15)
    Mucormycosis is a life-threatening invasive fungal infection that arises among immunocompromised patients (haematological malignancies, solid organ transplantation, diabetes mellitus). The most frequent sites of infection are pulmonary, rhinocerebral, cutaneous and disseminated. Reversal of the underlying conditions is mandatory for controlling
    Bao Zhang et al.
    Biochimica et biophysica acta, 1828(9), 2230-2237 (2013-06-13)
    Bacillomycin L, a natural iturinic lipopeptide produced by Bacillus amyloliquefaciens, is characterized by strong antifungal activities against a variety of agronomically important filamentous fungi including Rhizoctonia solani Kühn. Prior to this study, the role of membrane permeabilization in the antimicrobial
    Anil Bhansali et al.
    The Journal of the Association of Physicians of India, 60, 54-58 (2013-06-20)
    Histoplasmosis has been sporadically reported from India. Though asymptomatic adrenal involvement has been described in patients with disseminated histoplasmosis; isolated adrenal involvement with adrenal insufficiency (AI) as the presenting manifestation of the disease is rare. We describe 5 immunocompetent men
    View All Related Papers